Search Results - "O’Harte, Finbarr P. M."

Refine Results
  1. 1

    Long-term treatment with acylated analogues of apelin-13 amide ameliorates diabetes and improves lipid profile of high-fat fed mice by O'Harte, Finbarr P M, Parthsarathy, Vadivel, Hogg, Christopher, Flatt, Peter R

    Published in PloS one (29-08-2018)
    “…Previous studies have shown that modified apelin analogues exhibited enzyme resistance in plasma and improved circulating half-life compared to apelin-13. This…”
    Get full text
    Journal Article
  2. 2

    A novel DPP IV-resistant C-terminally extended glucagon analogue exhibits weight-lowering and diabetes-protective effects in high-fat-fed mice mediated through glucagon and GLP-1 receptor activation by Lynch, Aisling M., Pathak, Nupur, Pathak, Varun, O’Harte, Finbarr P. M., Flatt, Peter R., Irwin, Nigel, Gault, Victor A.

    Published in Diabetologia (01-09-2014)
    “…Aims/hypothesis Modification of the structure of glucagon could provide useful compounds for the potential treatment of obesity-related diabetes. Methods This…”
    Get full text
    Journal Article
  3. 3

    Potential Therapeutic Role for Apelin and Related Peptides in Diabetes: An Update by Palmer, Ethan S, Irwin, Nigel, O’Harte, Finbarr PM

    “…Type 2 diabetes mellitus (T2DM) is an epidemic with an ever-increasing global prevalence. Current treatment strategies, although plentiful and somewhat…”
    Get full text
    Book Review Journal Article
  4. 4

    Sustained glucagon receptor antagonism in insulin-deficient high-fat-fed mice by Lafferty, Ryan A, McShane, Laura M, Franklin, Zara J, Flatt, Peter R, O’Harte, Finbarr P M, Irwin, Nigel

    Published in Journal of endocrinology (01-11-2022)
    “…Discerning modification to the amino acid sequence of native glucagon can generate specific glucagon receptor (GCGR) antagonists, that include…”
    Get full text
    Journal Article
  5. 5

    Exendin-4 stimulates autophagy in pancreatic β-cells via the RAPGEF/EPAC-Ca2+-PPP3/calcineurin-TFEB axis by Zummo, Francesco P, Krishnanda, Stanislaus I, Georgiou, Merilin, O'Harte, Finbarr PM, Parthsarathy, Vadivel, Cullen, Kirsty S, Honkanen-Scott, Minna, Shaw, James AM, Lovat, Penny E, Arden, Catherine

    Published in Autophagy (03-04-2022)
    “…Macroautophagy/autophagy is critical for the regulation of pancreatic β-cell mass and its deregulation has been implicated in the pathogenesis of type 2…”
    Get full text
    Journal Article
  6. 6
  7. 7

    Proglucagon-Derived Peptides as Therapeutics by Lafferty, Ryan A, O'Harte, Finbarr P M, Irwin, Nigel, Gault, Victor A, Flatt, Peter R

    Published in Frontiers in endocrinology (Lausanne) (18-05-2021)
    “…Initially discovered as an impurity in insulin preparations, our understanding of the hyperglycaemic hormone glucagon has evolved markedly over subsequent…”
    Get full text
    Journal Article
  8. 8

    Physicochemical, Nutritional and In Vitro Antidiabetic Characterisation of Blue Whiting ( Micromesistius poutassou ) Protein Hydrolysates by Harnedy-Rothwell, Pádraigín A, Khatib, Neda, Sharkey, Shaun, Lafferty, Ryan A, Gite, Snehal, Whooley, Jason, O'Harte, Finbarr Pm, FitzGerald, Richard J

    Published in Marine drugs (02-07-2021)
    “…Protein hydrolysates from low-value underutilised fish species are potential sources of high-quality dietary protein and health enhancing peptides. Six blue…”
    Get full text
    Journal Article
  9. 9
  10. 10

    Inhibition of dipeptidyl peptidase-IV activity by metformin enhances the antidiabetic effects of glucagon-like peptide-1 by Green, Brian D., Irwin, Nigel, Duffy, Nicola A., Gault, Victor A., O'Harte, Finbarr P.M., Flatt, Peter R.

    Published in European journal of pharmacology (10-10-2006)
    “…GLP-1 and GIP are insulin-releasing ‘incretin’ hormones inactivated following degradation by dipeptidyl peptidase IV. Incretin hormone analogues resistant to…”
    Get full text
    Journal Article
  11. 11
  12. 12

    Fatty acid derivatised analogues of glucose-dependent insulinotropic polypeptide with improved antihyperglycaemic and insulinotropic properties by Kerr, Barry D., Irwin, Nigel, O’Harte, Finbarr P.M., Bailey, Clifford J., Flatt, Peter R., Gault, Victor A.

    Published in Biochemical pharmacology (15-10-2009)
    “…C-terminal acylation of Lys 37 with myristic (MYR; tetradecanoic acid), palmitic (PAL; hexadecanoic acid) and stearic (octadecanoic acid) fatty acids with or…”
    Get full text
    Journal Article
  13. 13

    Effects of antidiabetic drugs on dipeptidyl peptidase IV activity: Nateglinide is an inhibitor of DPP IV and augments the antidiabetic activity of glucagon-like peptide-1 by Duffy, Nicola A., Green, Brian D., Irwin, Nigel, Gault, Victor A., McKillop, Aine M., O'Harte, Finbarr P.M., Flatt, Peter R.

    Published in European journal of pharmacology (30-07-2007)
    “…Dipeptidyl peptidase IV (DPP IV) is the primary inactivator of glucoregulatory incretin hormones. This has lead to development of DPP IV inhibitors as a new…”
    Get full text
    Journal Article
  14. 14

    Atlantic salmon (Salmo salar) co-product-derived protein hydrolysates: A source of antidiabetic peptides by Harnedy, Pádraigín A., Parthsarathy, Vadivel, McLaughlin, Chris M., O'Keeffe, Martina B., Allsopp, Philip J., McSorley, Emeir M., O'Harte, Finbarr P.M., FitzGerald, Richard J.

    Published in Food research international (01-04-2018)
    “…Large quantities of low-value protein rich co-products, such as salmon skin and trimmings, are generated annually. These co-products can be upgraded to…”
    Get full text
    Journal Article
  15. 15

    Beneficial actions of a long‐acting apelin analogue in diabetes are related to positive effects on islet cell turnover and transdifferentiation by Tanday, Neil, Irwin, Nigel, Moffett, R. Charlotte, Flatt, Peter R., O'Harte, Finbarr P. M.

    Published in Diabetes, obesity & metabolism (01-12-2020)
    “…Aim The current study has tested the hypothesis that the positive effects of apelin receptor activation in diabetes are linked to benefits on islet cell…”
    Get full text
    Journal Article
  16. 16
  17. 17

    The bioactive conformation of glucose-dependent insulinotropic polypeptide by NMR and CD spectroscopy by Alaña, Iñigo, Malthouse, J. Paul G., O'Harte, Finbarr P. M., Hewage, Chandralal M.

    “…Glucose‐dependent insulinotropic polypeptide (GIP) is a gastrointestinal incretin hormone, which modulates physiological insulin secretion. Because of its…”
    Get full text
    Journal Article
  18. 18

    An update on galanin and spexin and their potential for the treatment of type 2 diabetes and related metabolic disorders by Gallagher, Daniel M, O'Harte, Finbarr P M, Irwin, Nigel

    Published in Peptides (New York, N.Y. : 1980) (01-01-2024)
    “…Spexin (SPX) and galanin (GAL) are two neuropeptides widely expressed in the central nervous system as well as within peripheral tissues in humans and other…”
    Get full text
    Journal Article
  19. 19

    Chronic apelin analogue administration is more effective than established incretin therapies for alleviating metabolic dysfunction in diabetic db/db mice by O'Harte, Finbarr P.M., Parthsarathy, Vadivel, Flatt, Peter R.

    Published in Molecular and cellular endocrinology (15-03-2020)
    “…Stable apelin-13 peptide analogues have shown promising acute antidiabetic effects in mice with diet-induced obesity diabetes. Here the efficacy of…”
    Get full text
    Journal Article
  20. 20

    Dual-agonist incretin peptides from fish with potential for obesity-related Type 2 diabetes therapy – A review by Conlon, J. Michael, O’Harte, Finbarr P.M., Flatt, Peter R.

    Published in Peptides (New York, N.Y. : 1980) (01-01-2022)
    “…•Proglucagon-derived peptide from phylogenetically ancient fish are dual-agonists at GLP1R and GCGR.•Paddlefish glucagon and lamprey GLP-1 are the most potent…”
    Get full text
    Journal Article